Comparison of Methotrexate Versus Interferon-alfa 2b on Efficacy, Safety and Quality of Life in Patients With Primary Cutaneous T-cell Lymphomas
Phase of Trial: Phase IV
Latest Information Update: 19 Jul 2017
At a glance
- Drugs Interferon alpha-2b (Primary) ; Methotrexate (Primary)
- Indications Cutaneous T cell lymphoma
- Focus Therapeutic Use
- 12 Jul 2017 Planned End Date changed from 1 May 2017 to 1 Dec 2017.
- 12 Jul 2017 Planned primary completion date changed from 1 May 2017 to 1 Dec 2017.
- 29 Dec 2014 New trial record